Does DONAFENIB Cause Palmar-plantar erythrodysaesthesia syndrome? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Palmar-plantar erythrodysaesthesia syndrome have been filed in association with DONAFENIB. This represents 16.2% of all adverse event reports for DONAFENIB.
6
Reports of Palmar-plantar erythrodysaesthesia syndrome with DONAFENIB
16.2%
of all DONAFENIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Palmar-plantar erythrodysaesthesia syndrome From DONAFENIB?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Palmar-plantar erythrodysaesthesia syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DONAFENIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DONAFENIB Cause?
Therapy partial responder (21)
Diarrhoea (6)
Rash (6)
Abdominal pain (5)
Hypertension (5)
Nausea (5)
Pyrexia (5)
Vomiting (5)
What Other Drugs Cause Palmar-plantar erythrodysaesthesia syndrome?
CAPECITABINE (5,294)
CABOZANTINIB S-MALATE (2,706)
REGORAFENIB (1,230)
LENVATINIB (1,211)
BEVACIZUMAB (1,079)
SORAFENIB (1,040)
OXALIPLATIN (980)
SUNITINIB MALATE (929)
TRASTUZUMAB (919)
FLUOROURACIL (837)